These 5 stocks have delivered jaw-dropping gains so far in 2019. Despite a volatile market, these are the tech stocks that have still managed to seriously outperform. We are talking returns of 70% + in just over five months. That’s as the tech-heavy Nasdaq index enters correction territory amid ongoing regulatory concerns for the FAANG stocks. But the question is, do these 5 tech stocks still make compelling investing opportunities right now? Here’s what the Street has to say…
CLDX: Strong Barzolvolimab Results Unveiled at EACCI!
Overview & Barzolvolimab Breakthrough Celldex Therapeutics (NASDAQ: CLDX) is a clinical-stage biotech focused on immunology, and it recently drew significant attention after unveiling compelling results
June 15, 2026
No Comments